Lyme-Arthritis bei Kindern

Zusammenfassung

Die Lyme-Arthritis ist durch die Infektion mit Borrelia burgdorferi sensu lato verursacht. In dieser Arbeit wird der aktuelle Wissensstand zu Epidemiologie, Mikrobiologie, Pathogenese sowie zu den klinischen Manifestationen und deren Diagnose, Behandlung und Prognose dargestellt, besonders bezogen auf das Kindes- und Jugendalter.

Summary

Lyme arthritis is caused by infection with Borrelia burgdorferi sensu lato. This article reviews the current understanding of the epidemiology, microbiology, pathogenesis as well as the clinical manifestations and their diagnosis, treatment and prognosis with special emphasis on children and adolescents.

Schlüsselwörter

Lyme-Arthritis - Kinder - Jugendliche - Borrelia burgdorferi

Keywords

Lyme arthritis - children - adolescents - Borrelia burgdorferi

• Literatur

• 1 Adams WV, Rose CD, Eppes SC. et al. Cognitive effects of Lyme disease in children: a 4 year followup study. J Rheumatol 1999; 26: 1190-1194.
• 2 Bentas W, Karch H, Huppertz HI. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000; 27: 2025-2030.
• 3 Carlson D, Hernandez J, Bloom BJ. et al. Lack of Borrelia burgdorferi DNA in synovial fluid samples from patients with antibiotic treatment–resistant Lyme arthritis. Arthritis Rheum 1999; 42: 2705-2709.
• 4 Dressler F, Huppertz HI. Lyme-Arthritis bei Kindern und Jugendlichen. Z Rheumatol 2008; 67: 121-127.
• 5 Ecklund K, Vargas S, Zurakowski D, Sundel RP. MRI features of Lyme arthritis in children. Am J Roentgenol 2005; 184: 1904-1909.
• 6 Eckman MH, Steere AC, Kalish RA. et al. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997; 337: 357-363.
• 7 Gerber MA, Shapiro ED, Burke GS. et al. Lyme disease in children in southeastern Connecticut. N Engl J Med 1996; 335: 1270-1274.
• 8 Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998; 102: 905-908.
• 9 Golightly M. Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am J Clin Pathol 1993; 99: 168-174.
• 10 Hammers-Berggren S, Andersson U, Stiernstedt G. Borrelia arthritis in Swedish children: clinical manifestations in 10 children. Acta Paediatr 1992; 81: 921-924.
• 11 Hauser U, Lehnert G, Wilkske B. Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 1999; 37: 2241-2247.
• 12 Hayes EB, Piesman J. How can we prevent Lyme disease?. N Engl J Med 2003; 348: 2424-2430.
• 13 Huppertz HI, Bentas W, Haubitz I. et al. Diagnosis of pediatric Lyme arthritis using a clinical score. Eur J Pediatr 1998; 157: 304-308.
• 14 Huppertz HI, Böhme M, Standaert SM. et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
• 15 Huppertz HI, Dressler F. Lyme disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. eds. Textbook of Pediatric Rheumatology. 6th edition. Philadelphia (USA): Elsevier Saunders; 2010: 579-590.
• 16 Huppertz HI, Karch H, Heesemann J. Diagnostic value of synovial fluid analysis in children with reactive arthritis. Rheumatol Int 1995; 15: 167-170.
• 17 Huppertz HI, Karch H, Suschke HJ. et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995; 38: 361-368.
• 18 Huppertz HI, Michels H. Pattern of joint involvement in children with Lyme arthritis. Br J Rheumatol 1996; 35: 1016-1018.
• 19 Huppertz HI, Mösbauer S, Busch DH. et al. Lympho proliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur J Pediatr 1996; 155: 297-302.
• 20 Huppertz HI, Münchmeier D, Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol 1999; 83: 1149.
• 21 Jaulhac B, Chary-Valckenaere I, Sibila J. et al Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996; 39: 736-745.
• 22 Karch H, Huppertz HI, Böhme M. et al. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi–specific antibodies. J Clin Microbiol 1994; 32: 2312.
• 23 Milewski MD, Cruz AI, Miller CP. et al. Lyme arthritis in children presenting with joint effusions. J Bone Joint Surg Am 2011; 93: 252-260.
• 24 Nichol G, Dennis DT, Steere AC. et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Intern Med 1998; 128: 37-48.
• 25 Nocton JJ, Dressler F, Rutledge BJ. et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-234.
• 26 Priem S, Rittig MG, Kamradt T. et al. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol 1997; 35: 685-690.
• 27 Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. MMWR 1995; 44: 590-591.
• 28 Richter D, Postic D, Sertour N. et al. Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of Borrelia spielmanii sp. Nov. Int J Syst Evol Microbiol 2006; 56: 873-881.
• 29 Rose CD, Fawcett PT, Gibney KM. et al. Residual serologic reactivity in children with resolved Lyme arthritis. J Rheumatol 1996; 23: 367-369.
• 30 Salazar JC, Gerber MA, Goff CW. Long-term outcome of Lyme disease in children given early treatment. J Pediatr 1993; 122: 591-593.
• 31 Schutzer SE, Fraser-Liggett CM, Casjens SR. et al. Whole genome sequences of thirteen isolates of Borrelia burgdorferi . J Bacteriol 2011; 193: 1018-1020.
• 32 Shin JJ, Glickstein LJ, Steere AC. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum 2007; 56: 1325-1335.
• 33 Sigal LH, Patella SJ. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 1992; 90: 523-528.
• 34 Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 2004; 4: 143-152.
• 35 Steere AC, Levin RE, Molloy PJ. et al. Treatment of Lyme arthritis. Arthritis Rheum 1994; 37: 878-888.
• 36 Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children. N Engl J Med 1991; 325: 159-163.
• 37 Thorstrand C, Belfrage E, Bennet R. et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J 2002; 21: 1142-1145.
• 38 Tory HO, Zurakowski D, Sundel RP. Outcomes for children treated for Lyme arthritis: results of a large pediatric cohort. J Rheumatol 2010; 37: 1049-1055.
• 39 Wormser GP, Dattwyler RJ, Shapiro ED. et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplosmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-1134.
• 40 Zahid Qureshi M, New D, Zulqarni NJ, Nachman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 2002; 21: 12.